ROYAL BANK OF CANADA - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 73 filers reported holding IMMUNE DESIGN CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$9,000
-50.0%
1,615
-88.4%
0.00%
Q4 2018$18,000
-67.3%
13,927
-12.1%
0.00%
Q3 2018$55,000
+243.8%
15,853
+374.6%
0.00%
Q2 2018$16,000
+45.5%
3,340
+3.3%
0.00%
Q1 2018$11,000
-15.4%
3,233
+0.6%
0.00%
Q4 2017$13,000
-23.5%
3,215
+100.7%
0.00%
Q3 2017$17,000
+325.0%
1,602
+154.3%
0.00%
Q1 2017$4,000
-20.0%
630
-29.1%
0.00%
Q4 2016$5,000
+400.0%
888
+1133.3%
0.00%
Q3 2016$1,00072
+132.3%
0.00%
Q4 2015$0
-100.0%
31
-93.6%
0.00%
Q3 2015$6,000
-73.9%
482
-57.9%
0.00%
Q2 2015$23,0001,1460.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders